Description
Notes:
Production, means the output of Active Pharma Ingredient
Revenue, means the sales value of Active Pharma Ingredient
This report studies Active Pharma Ingredient in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Teva
DSM
Novartis
Johnson?&?Johnson
Dr. Reddy?s
Pfizer
Bayer
BASF
Cambrex
Sun Pharmaceutical
Lonza group
Boehringer Ingelheim
Aurobindo pharma
Lupin
Biocon
Cipla
Haerbin Pharmaceutical
North East Pharmaceutical
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Active Pharma Ingredient in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Vitamin
Antibiotic
Antipyretic and Analgesic Activities
Hormone
Amino Acid
Cardiovascular
Split by application, this report focuses on consumption, market share and growth rate of Active Pharma Ingredient in each application, can be divided into
Application 1
Application 2
Application 3
Table of contents
Table of Contents
Global Active Pharma Ingredient Market Research Report 2016
1 Active Pharma Ingredient Market Overview
1.1 Product Overview and Scope of Active Pharma Ingredient
1.2 Active Pharma Ingredient Segment by Type
1.2.1 Global Production Market Share of Active Pharma Ingredient by Type in 2015
1.2.2 Vitamin
1.2.3 Antibiotic
1.2.4 Antipyretic and Analgesic Activities
1.2.5 Hormone
1.2.6 Amino Acid
1.2.7 Cardiovascular
1.3 Active Pharma Ingredient Segment by Application
1.3.1 Active Pharma Ingredient Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Active Pharma Ingredient Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Active Pharma Ingredient (2011-2021)2 Global Active Pharma Ingredient Market Competition by Manufacturers
2.1 Global Active Pharma Ingredient Production and Share by Manufacturers (2015 and 2016)
2.2 Global Active Pharma Ingredient Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Active Pharma Ingredient Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Active Pharma Ingredient Manufacturing Base Distribution, Sales Area and Product Type
2.5 Active Pharma Ingredient Market Competitive Situation and Trends
2.5.1 Active Pharma Ingredient Market Concentration Rate
2.5.2 Active Pharma Ingredient Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion3 Global Active Pharma Ingredient Production, Revenue (Value) by Region (2011-2016)
3.1 Global Active Pharma Ingredient Production and Market Share by Region (2011-2016)
3.2 Global Active Pharma Ingredient Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2011-2016)4 Global Active Pharma Ingredient Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Active Pharma Ingredient Consumption by Regions (2011-2016)
4.2 North America Active Pharma Ingredient Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Active Pharma Ingredient Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Active Pharma Ingredient Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Active Pharma Ingredient Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Active Pharma Ingredient Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Active Pharma Ingredient Production, Consumption, Export, Import by Regions (2011-2016)5 Global Active Pharma Ingredient Production, Revenue (Value), Price Trend by Type
5.1 Global Active Pharma Ingredient Production and Market Share by Type (2011-2016)
5.2 Global Active Pharma Ingredient Revenue and Market Share by Type (2011-2016)
5.3 Global Active Pharma Ingredient Price by Type (2011-2016)
5.4 Global Active Pharma Ingredient Production Growth by Type (2011-2016)6 Global Active Pharma Ingredient Market Analysis by Application
6.1 Global Active Pharma Ingredient Consumption and Market Share by Application (2011-2016)
6.2 Global Active Pharma Ingredient Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries7 Global Active Pharma Ingredient Manufacturers Profiles/Analysis
7.1 Teva
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Active Pharma Ingredient Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Teva Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 DSM
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Active Pharma Ingredient Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 DSM Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Novartis
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Active Pharma Ingredient Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Novartis Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Johnson?&?Johnson
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Active Pharma Ingredient Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Johnson?&?Johnson Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Dr. Reddy?s
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Active Pharma Ingredient Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Dr. Reddy?s Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Pfizer
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Active Pharma Ingredient Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Pfizer Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Bayer
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Active Pharma Ingredient Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Bayer Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 BASF
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Active Pharma Ingredient Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 BASF Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Cambrex
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Active Pharma Ingredient Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Cambrex Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Sun Pharmaceutical
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Active Pharma Ingredient Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Sun Pharmaceutical Active Pharma Ingredient Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Lonza group
7.12 Boehringer Ingelheim
7.13 Aurobindo pharma
7.14 Lupin
7.15 Biocon
7.16 Cipla
7.17 Haerbin Pharmaceutical
7.18 North East Pharmaceutical8 Active Pharma Ingredient Manufacturing Cost Analysis
8.1 Active Pharma Ingredient Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Active Pharma Ingredient9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Active Pharma Ingredient Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Active Pharma Ingredient Major Manufacturers in 2015
9.4 Downstream Buyers10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change12 Global Active Pharma Ingredient Market Forecast (2016-2021)
12.1 Global Active Pharma Ingredient Production, Revenue Forecast (2016-2021)
12.2 Global Active Pharma Ingredient Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Active Pharma Ingredient Production Forecast by Type (2016-2021)
12.4 Global Active Pharma Ingredient Consumption Forecast by Application (2016-2021)
12.5 Active Pharma Ingredient Price Forecast (2016-2021)13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer
